Overview

Biosimulation Market Introduction:

Biosimulation Market is predicted to value over USD 4 billion by 2027 end with a CAGR of over 15% during the forecast period 2020 to 2027.

Bio-simulation is a distinct part of systems biology, which gives information about complex biological systems in disease and health. The bio-simulation is also referred to as in-silico biology, which means biological experiments have to carry out in the computer. It is an entirely new concept in the drug development industry, which relies on expressing the biological systems with mathematical expressions, thus, capturing biological elements and their relationships, and simulating the behaviour of certain systems in different situations. There are different types of bio-simulation approaches are available which gives outcome based on the complexity of biosystem and the disease- drug target. It credits the reduction and replacement of animal and human experimentations as well as improves the knowledge of how patients need to administer medicine.

Biosimulation has a huge demand for drug development for mimicking disease indication. It is used to simulate the disease indication and decrease the effort of research. Increasing attrition rates of drug development have increased the dependence of research companies on simulation techniques for minimizing capital investments. Additionally, the rapid advancement of technologies has integrated the biosimulation process in clinical trials and offers complete automation. Biosimulation techniques also minimize human errors and increase the efficiency of the development process. Further, it also decreases the development time and speeds up the whole drug discovery process. All these factors led to robust growth of the market during the forecast period. Global Biosimulation market is expected to witness a high adoption rate due to increasing awareness of simulation techniques among the drug developing companies.

North America market is expected to account major share in the global market due to high R&D investments of top drug manufacturers. It was followed by the European region and it also accounts significant share over the forecast period. It is expected to witness high growth rate over the forecast period. Both North America and Europe market is expected to remain dominant in the global market over the forecast period. The Asia Pacific, Latin America and Rest of the world market are expected to account a small fraction of market share due to less adoption.

Biosimulation market players include
Certara, Simulations Plus, Dassault Systèmes, Schrödinger, ACD/Labs, Chemical Computing Group, Physiomics, Evidera, In silico biosciences, INOSIM Software, Insilico Biotechnology, LeadInvent Technologies, Rosa, Nuventra Pharma , and Genedata.

                                                       Biosimulation Market
Biosimulation Market Segmentation:

By Product & Service

  • Software
  • Molecular Modeling and Simulation Software
  • PBPK Modeling and Simulation Software
  • PK/PD Modeling and Simulation Software
  • Trial Design Software
  • Toxicity Prediction Software
  • Other Biosimulation Software
  • Services
  • In-house Services
  • Contract Services

By Application

  • Drug Development
  • Drug Discovery    
  • Other Applications              

By Delivery Model

  • Subscription Models
  • Ownership Models

By End User

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Contract Research Organizations
  • Regulatory Authorities
  • Other End Users

By Region  

  • Europe  
  • North America  
  • APAC  
  • Latin America 
  • Rest of World 

Competitive Landscape: 

  • Tier 1 players- established companies in the market with a major market share  
  • Tier 2 players 
  • Emerging players which are growing rapidly 
  • New Entrants   

 FutureWise Takeaways:  

  • Growth prospects  
  • SWOT analysis 
  • Key trends 
  • Key data-points affecting market growth

Objectives of the Study:

  • To provide with an exhaustive analysis on the global market by product & service, by application, by delivery model, by end user and by region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) 
  • To evaluate and forecast micro-markets and the overall market  
  • To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East 
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies 

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: 
sales@futurewiseresearch.com

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics